Researcher discovers way to overcome radiation resistance in leukemia

Sep 30, 2010
This is Fatih Uckun, M.D., Ph.D., of Childrens Hospital Los Angeles. Credit: Courtesy of Dr Uckun

A team of researchers lead by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Childrens Hospital Los Angeles has determined that radiation resistance in leukemia can be overcome by selectively attacking a molecular target known as SYK tyrosine kinase.

B-lineage (ALL) is the most common cancer occurring in children and adolescents. Despite having received intensive chemotherapy, some patients have recurring disease, known as relapse. For these individuals, the prospect of long-term survival is poor.

The standard approach to treating relapsed patients has been additional chemotherapy to achieve a second remission followed by very intensive treatment that could include "supralethal" chemotherapy, total-body irradiation (TBI), and hematopoietic . However, radiation resistance of hampers the success of these rigorous therapeutic approaches and results in poor survival.

"We knew that we could kill radiation-resistant leukemia cells if we only knew what made them so resistant. So we set out to determine the mechanism," said Dr. Uckun, who is also professor of Research Pediatrics at the Keck School of Medicine at the University of Southern California. "Once we determined the mechanism, the next step was obvious -- to rationally design a drug that would take out that specific target."

Uckun's research team has now provided the first proof-of-principle that radiation resistance of an aggressive leukemia can indeed be overcome using this rationally-designed specific drug directed against the resistance machinery of leukemia cells.

" was much more effective against leukemia in mice when it was combined with this new that we named C-61," said Dr. Uckun.

Explore further: Team finds new genetic anomalies in lung cancer

More information: The results of the study will be published in the October 2010 issue of Radiation Research.

Provided by Children's Hospital Los Angeles

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Combination therapy targets stubborn leukemia stem cells

May 17, 2010

New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the ne ...

Recommended for you

Bone loss drugs may help prevent endometrial cancer

5 hours ago

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...

Putting the brakes on cancer

Dec 19, 2014

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.